pH-responsive alginate-hyaluronic acid microbeads produced via optimized electrospray method for oral ibuprofen delivery
Abstract
Encapsulating active compounds in alginate-hyaluronic acid (ALG-HA) microbeads provides a biocompatible, calcium-cross-linkable platform for oral nonsteroidal anti-inflammatory drug delivery with the potential to minimize gastric drug release and promote intestinal release. To address the challenge of achieving uniformly spherical beads with narrow size distributions, we used electrospraying to generate ALG-HA droplets and subsequently ionotropically cross-linked them using calcium chloride. Bead size and morphology were characterized, rheology of pre-gel polymer solutions was assessed, and ibuprofen encapsulation and release were evaluated in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). The process yielded spherical microbeads with a narrow size distribution and consistent morphology, exhibiting mean diameters of 2456 ± 146 μm and 638 ± 170 μm, with PDI values ranging from 0.0035 to 0.0706. Ibuprofen release remained low in SGF and increased in SIF, demonstrating pH-responsive release behaviour. Electrosprayed, calcium crosslinked ALG-HA microbeads therefore constitute a promising platform for the oral delivery of ibuprofen, with potential for minimizing gastric drug release and promoting intestinal release. To our knowledge, this is the first assessment of electrosprayed, calcium cross-linked ALG-HA microbeads for pH-responsive ibuprofen delivery.
Related
- Hyaluronic acid-based osmolality-responsive immediate-release microneedles co-loading baicalein and astaxanthin for oral ulcer therapy.
- Dissolving hyaluronic acid microparticles improve skin barrier function, hydration, and elasticity in a randomized split-face clinical trial
- Beyond Phenylbutyric Acid: Evans Blue and Ibuprofen as Albumin- Binding Motifs for PSMA-Targeted Radioligand Therapy of Prostate Cancer
- Efficacy, Durability, and Safety of VYC‐17.5L Hyaluronic Acid Dermal Filler for Facial Enhancement: A Systematic Review and Single‐Arm Meta‐Analysis
- An ibuprofen-eluting electrospun membrane prevents ureteral fibrosis by dampening macrophage-associated fibroblast activation
BibTeX
@article{abid2026phresponsive,
title = {{pH-responsive alginate-hyaluronic acid microbeads produced via optimized electrospray method for oral ibuprofen delivery}},
author = {Ali Imran Abid and Nicolas Anton and Mohamed Elhassan and Nadia Jessel and Thierry Vandamme and Guillaume Conzatti},
journal = {Journal of Drug Delivery Science and Technology},
year = {2026},
month = sep,
doi = {10.1016/j.jddst.2026.108975},
url = {https://univoak.hal.science/hal-05764039v1},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - pH-responsive alginate-hyaluronic acid microbeads produced via optimized electrospray method for oral ibuprofen delivery
AU - Ali Imran Abid
AU - Nicolas Anton
AU - Mohamed Elhassan
AU - Nadia Jessel
AU - Thierry Vandamme
AU - Guillaume Conzatti
PY - 2026
DA - 2026/09/25
JO - Journal of Drug Delivery Science and Technology
DO - 10.1016/j.jddst.2026.108975
UR - https://univoak.hal.science/hal-05764039v1
AB - Encapsulating active compounds in alginate-hyaluronic acid (ALG-HA) microbeads provides a biocompatible, calcium-cross-linkable platform for oral nonsteroidal anti-inflammatory drug delivery with the potential to minimize gastric drug release and promote intestinal release. To address the challenge of achieving uniformly spherical beads with narrow size distributions, we used electrospraying to generate ALG-HA droplets and subsequently ionotropically cross-linked them using calcium chloride. Bead size and morphology were characterized, rheology of pre-gel polymer solutions was assessed, and ibuprofen encapsulation and release were evaluated in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). The process yielded spherical microbeads with a narrow size distribution and consistent morphology, exhibiting mean diameters of 2456 ± 146 μm and 638 ± 170 μm, with PDI values ranging from 0.0035 to 0.0706. Ibuprofen release remained low in SGF and increased in SIF, demonstrating pH-responsive release behaviour. Electrosprayed, calcium crosslinked ALG-HA microbeads therefore constitute a promising platform for the oral delivery of ibuprofen, with potential for minimizing gastric drug release and promoting intestinal release. To our knowledge, this is the first assessment of electrosprayed, calcium cross-linked ALG-HA microbeads for pH-responsive ibuprofen delivery.
SN - 1773-2247
ER -